TOP TIERMARKET NEWSWIRE
News & sentiment

AMNEAL PHARMACEUTICA A (AMRX) — News & AI sentiment

AMNEAL PHARMACEUTICA A (AMRX) news roundup. 3 stories in the past week, 6 over 30 days. Average 30-day sentiment is 55.3/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $7.2M — net selling of $7.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 57/100
30d stories
6
avg sentiment 55.3/100
Insider net (90d)
$7.2M
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

AMRX news in the last 24 hours, 7 days, 30 days and 90 days

How much AMRX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAMRX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days357/100AMRX headlines →
Last 30 days655.3/100AMRX headlines →
Last 90 days3257/100AMRX headlines →

Latest stories on AMRX

2d ago
5d ago
6d ago
Oct 8
Oct 2
UBS reiterates Amneal Pharmaceuticals stock Buy rating on HRT growth
Investing.com Analyst Ratings61 · neutralanalyst
Oct 1
Oppenheimer initiates Amneal Pharmaceuticals stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Sep 23
Sep 23
Sep 22
Sep 21
Sep 21
Sep 18
Sep 18
Sep 18
Sep 18
Sep 9
Sep 9
Sep 4
Sep 3
Aug 26
Aug 10
Aug 10
Aug 10
Amneal (AMRX) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Aug 3
Aug 3
Open AMRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →